Helpful Info. What everyone must do to defeat Covid19

Doomsday Prepper Forums

Help Support Doomsday Prepper Forums:

This site may earn a commission from merchant affiliate links, including eBay, Amazon, and others.
https://www.google.com/url?sa=t&rct...ay-19-update&usg=AOvVaw22IWdZIRMgVYaHLRKLMURY
I could post many links with a similar review but this one seemed fairly non biased. I’m not going to change anyone’s opinion on this here and that’s ok, but I am a big believer in science and not rumors or conjecture. I have read articles saying there are potential benefits for this drug, but they were mostly based on small trials. The majority of what I’ve read is saying it’s not very effective. I still will trust the majority of medical experts and scientists over trump or even the CDC, which is just one group.
So far the only thing I’m reading that most studies indicate is really helping is Remdesivir. It isn’t a cure but does seem to shorten the duration of the illness.
 
https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwi4xuud8czpAhWlmOAKHSCzB28QFjAQegQIARAB&url=https://blogs.sciencemag.org/pipeline/archives/2020/05/19/taking-hydroxychloroquine-may-19-update&usg=AOvVaw22IWdZIRMgVYaHLRKLMURY
I could post many links with a similar review but this one seemed fairly non biased. I’m not going to cha
nge anyone’s opinion on this here and that’s ok, but I am a big believer in science and not rumors or conjecture. I have read articles saying there are potential benefits for this drug, but they were mostly based on small trials. The majority of what I’ve read is saying it’s not very effective. I still will trust the majority of medical experts and scientists over trump or even the CDC, which is just one group.
So far the only thing I’m reading that most studies indicate is really helping is Remdesivir. It isn’t a cure but does seem to shorten the duration of the illness.

Ok Brent, there some useful data there
Also a lot of bad data and a he'll of a lot of conjecture. The studies this author is referring to doesn't say what he says they say. Remdesiv has been shown to not do much of anything in every study. Far less beneficial than HCQ and Zinc, which are prophylactics, they prevent the virus from replicating, they do no good once the virus has done the damage and no longer needs to multiple. To cure the disease you need your bodies curative functions to kick in. To help your body do this, you need anti oxidents like vitamin C and chlorine dioxide. Remdesiv still has potential to be of a benefit in conjunction with other treatments.
 
Last edited:
Brent where are these studies you talked about?
That is an opinion blog in a magazine, not a scientific study in a journal. Just because a magazine has "Science" in the name doesn't make the articles scientific studies. Give me links to the scientific studies, like I gave you.
 
Last edited:
Brent where are these studies you talked about?
That is an opinion blog in a magazine, not a scientific study in a journal. Just because a magazine has "Science" in the name doesn't make the articles scientific studies. Give me links to the scientific studies, like I gave you.

I know Doc, he says "I am a big believer in science and not rumors or conjecture." And then he gives us an article of opinion and conjecture.
 
Also NOT a scientific article in a scientific journal.

WHO? Seriously? You're going to believe THEM???

6sjWKID.png
 
Watch this excellent video on breaking down the Lancet observational study on Hydroxychloriquin. Its explains how it is complete fiction and has no scientific basis for its conclusions.

 
https://newyork.cbslocal.com/2020/0...he-hydroxychloroquine-treatment-for-covid-19/
Coronavirus Drug Exclusive: Meet The Doctor Behind The Hydroxychloroquine Treatment, And What’s Next For Its Use
Zelenko prescribes the malaria drug hydroxychloroquine but only when two other substances are added, an antibiotic and zinc.

“All the hydroxychloroquine does is open the door and let the zinc in,” said Zelenko, a board-certified family physician.

It’s Zelenko’s combination of meds given early on when people first get sick that makes his protocol unique. He claims of his 400 patients at high risk for severe illness, only two died.

In New York State, though, that’s a Catch-22. To prevent shortages, pharmacists can only dispense hydroxychloroquine for severe hospital-based cases. By then, Zelenko says it’s ineffective.

“There is a very narrow window of opportunity where you can hit this virus hard and early where it makes all the difference,” said Zelenko.

Now science will weigh in. St. Francis Hospital in Roslyn is launching a study using essentially Zelenko’s cocktail. On newly symptomatic patients with underlying conditions, Hydroxychloroquine and zinc will be given to all of them.

Two groups will receive different antibiotics.

Cardiologist Dr. Avni Thakore is the study’s principal investigator.

“What we know about the mechanism of action of the drugs suggests they could be helpful early in the course of a viral infection,” said Thakore. “We know zinc is an anti-viral. We know that hydroxychloroquine can help reduce an immune response that can get out of control. We also know zinc helps the hydroxychloroquine come inside the cell.”

Administered early, rather than as a Hail Mary for the sickest which has had disappointing results, and to protect participants from any increased heart risk that have prompted safety concerns, Thakore notes “we are going to be monitoring their EKG from home.”
 
https://newyork.cbslocal.com/2020/0...he-hydroxychloroquine-treatment-for-covid-19/
Coronavirus Drug Exclusive: Meet The Doctor Behind The Hydroxychloroquine Treatment, And What’s Next For Its Use
Zelenko prescribes the malaria drug hydroxychloroquine but only when two other substances are added, an antibiotic and zinc.

“All the hydroxychloroquine does is open the door and let the zinc in,” said Zelenko, a board-certified family physician.

It’s Zelenko’s combination of meds given early on when people first get sick that makes his protocol unique. He claims of his 400 patients at high risk for severe illness, only two died.

In New York State, though, that’s a Catch-22. To prevent shortages, pharmacists can only dispense hydroxychloroquine for severe hospital-based cases. By then, Zelenko says it’s ineffective.

“There is a very narrow window of opportunity where you can hit this virus hard and early where it makes all the difference,” said Zelenko.

Now science will weigh in. St. Francis Hospital in Roslyn is launching a study using essentially Zelenko’s cocktail. On newly symptomatic patients with underlying conditions, Hydroxychloroquine and zinc will be given to all of them.

Two groups will receive different antibiotics.

Cardiologist Dr. Avni Thakore is the study’s principal investigator.

“What we know about the mechanism of action of the drugs suggests they could be helpful early in the course of a viral infection,” said Thakore. “We know zinc is an anti-viral. We know that hydroxychloroquine can help reduce an immune response that can get out of control. We also know zinc helps the hydroxychloroquine come inside the cell.”

Administered early, rather than as a Hail Mary for the sickest which has had disappointing results, and to protect participants from any increased heart risk that have prompted safety concerns, Thakore notes “we are going to be monitoring their EKG from home.”
This sounds like an interesting trial to follow. I hope it shows good results. Of course if this pans out then in order to implement this protocol early then catching COVID cases early will be very important. I would really like to see if it works for those who are most likely to get seriously ill, when the case is caught early. If it can prevent the illness from becoming severe in someone with diabetes, heart disease, COPD, auto immune disease, or the elderly, then that would be great because once someone in those groups has a severe case they are very unlikely to recover.
 
https://newyork.cbslocal.com/2020/0...he-hydroxychloroquine-treatment-for-covid-19/
Coronavirus Drug Exclusive: Meet The Doctor Behind The Hydroxychloroquine Treatment, And What’s Next For Its Use
Zelenko prescribes the malaria drug hydroxychloroquine but only when two other substances are added, an antibiotic and zinc.

“All the hydroxychloroquine does is open the door and let the zinc in,” said Zelenko, a board-certified family physician.

It’s Zelenko’s combination of meds given early on when people first get sick that makes his protocol unique. He claims of his 400 patients at high risk for severe illness, only two died.

In New York State, though, that’s a Catch-22. To prevent shortages, pharmacists can only dispense hydroxychloroquine for severe hospital-based cases. By then, Zelenko says it’s ineffective.

“There is a very narrow window of opportunity where you can hit this virus hard and early where it makes all the difference,” said Zelenko.

Now science will weigh in. St. Francis Hospital in Roslyn is launching a study using essentially Zelenko’s cocktail. On newly symptomatic patients with underlying conditions, Hydroxychloroquine and zinc will be given to all of them.

Two groups will receive different antibiotics.

Cardiologist Dr. Avni Thakore is the study’s principal investigator.

“What we know about the mechanism of action of the drugs suggests they could be helpful early in the course of a viral infection,” said Thakore. “We know zinc is an anti-viral. We know that hydroxychloroquine can help reduce an immune response that can get out of control. We also know zinc helps the hydroxychloroquine come inside the cell.”

Administered early, rather than as a Hail Mary for the sickest which has had disappointing results, and to protect participants from any increased heart risk that have prompted safety concerns, Thakore notes “we are going to be monitoring their EKG from home.”
This is a good example of where my views on this drug come from. This sounds like a good trial to learn from. Before I am ever going to endorse any kind of medical treatments I want this kind of research to have been done by multiple studies. I think when you are at deaths door from an new or unknown thing Like this virus has been then sure, try anything in the hopes that something will be discovered as effective treatment. BUT I don’t agree with the prophylactic use of un studied and unproven drugs. In this case the side affects to the heart are a real concern. It may end up being useful at some time, but until the benefits, safety, combinations with other drugs and dosage are well studied I just don’t see promoting it or any other new treatment as a good thing. The disgraced televangelist Jim Baker selling coronavirus cures on his show comes to mind.
 
BUT I don’t agree with the prophylactic use of un studied and unproven drugs.
You must be talking about that new unproven drug Fauci and WHO have been hyping, Remdesivir. Because Hydroxychloroquine has been extensively studied and WIDELY PRESCRIBED globally for 70 years.
 
You must be talking about that new unproven drug Fauci and WHO have been hyping, Remdesivir. Because Hydroxychloroquine has been extensively studied and WIDELY PRESCRIBED globally for 70 years.
Yes, but for the treatment of malaria. Even though Remdesivir is looking good in the initial trials it still hasn’t been proven safe or effective yet either.
 
Yes, but for the treatment of malaria.

1982 Study
https://pubmed.ncbi.nlm.nih.gov/6290597/
Inhibition of Vesicular Stomatitis Virus Glycoprotein Expression by Chloroquine

1990 Study
https://pubmed.ncbi.nlm.nih.gov/1692728/
Inhibition of Human Immunodeficiency Virus Infectivity by Chloroquine

1996 Study
https://pubmed.ncbi.nlm.nih.gov/8546725/
The Antiinflammatory and Antiviral Effects of Hydroxychloroquine in Two Patients With Acquired Immunodeficiency Syndrome and Active Inflammatory Arthritis

2003 Study
https://www.sciencedirect.com/science/article/pii/S1473309903008065
Effects of chloroquine on viral infections: an old drug against today's diseases

2004 Study
https://pubmed.ncbi.nlm.nih.gov/15076236/
Anti-HIV Effects of Chloroquine: Inhibition of Viral Particle Glycosylation and Synergism With Protease Inhibitors

2004 Study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092815/
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine

2005 Study
https://pubmed.ncbi.nlm.nih.gov/16115318/
Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread

 

Latest posts

Back
Top